These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8191267)

  • 41. Effectiveness of low-dose intramuscular anti-VHB immune globulin in the prophylaxis of viral B hepatitis reinfection after liver transplantation: preliminary report.
    Alonso I; Herreros de Tejada A; Moreno JM; Rubio E; Lucena JL; De la Revilla J; Sánchez Turrión V; Gomez A; Lopez J; Cuervas-Mons V
    Transplant Proc; 2003 Aug; 35(5):1850-1. PubMed ID: 12962821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Excellent liver transplantation survival and prevention of hepatitis B recurrence using hepatitis B immunoglobulin and nucleoside or nucleotide analogue along with treating physician adherence to treatment protocol.
    Lindenger C; Castedal M; Cahlin C; Friman S
    Transplant Proc; 2013 Apr; 45(3):1188-92. PubMed ID: 23622656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis.
    Lerut JP; Donataccio M; Ciccarelli O; Roggen F; Jamart J; Laterre PF; Cornu C; Mazza D; Hanique G; Rahier J; Geubel AP; Otte JB
    J Hepatol; 1999 Apr; 30(4):706-14. PubMed ID: 10207814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Liver transplantation and hepatitis B virus. Some reasons to advance].
    Samuel D
    Gastroenterol Clin Biol; 1992; 16(5):421-4. PubMed ID: 1382029
    [No Abstract]   [Full Text] [Related]  

  • 46. Hepatitis B-associated liver cirrhosis as an indication for liver transplantation.
    Jansen PL; Haagsma EB; Klompmaker IJ; Cuypers HT; Karrenbeld A; Gouw AS; Slooff MJ
    Scand J Gastroenterol Suppl; 1995; 212():19-22. PubMed ID: 8578227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis.
    Carman WF; Trautwein C; van Deursen FJ; Colman K; Dornan E; McIntyre G; Waters J; Kliem V; Müller R; Thomas HC; Manns MP
    Hepatology; 1996 Sep; 24(3):489-93. PubMed ID: 8781312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients.
    Samuel D; Bismuth A; Mathieu D; Arulnaden JL; Reynes M; Benhamou JP; Brechot C; Bismuth H
    Lancet; 1991 Apr; 337(8745):813-5. PubMed ID: 1672913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence. The European Cooperative Study Group on Liver Cancer and Transplantation.
    Mazzaferro V; Regalia E; Montalto F; Pulvirenti A; Brunetto MR; Bonino F; Lerut J; Gennari L
    Liver; 1996 Apr; 16(2):117-22. PubMed ID: 8740845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Orthotopic liver transplantation in hepatic cirrhosis: on the problem of infection of the transplant with persistent hepatitis viruses].
    Hopf U; Neuhaus P; König V; Bauditz J; Küther S; Schmidt CA; Steffen R; Blumhardt G; Bechstein WO; Neuhaus R
    Z Gastroenterol; 1992 Sep; 30(9):576-82. PubMed ID: 1449005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?
    Brancaccio G; Gaeta GB
    Ann Transplant; 2020 Mar; 25():e920969. PubMed ID: 32231174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B.
    Phillips MJ; Cameron R; Flowers MA; Blendis LM; Greig PD; Wanless I; Sherman M; Superina R; Langer B; Levy GA
    Am J Pathol; 1992 Jun; 140(6):1295-308. PubMed ID: 1376555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization.
    McGory RW; Ishitani MB; Oliveira WM; Stevenson WC; McCullough CS; Dickson RC; Caldwell SH; Pruett TL
    Transplantation; 1996 May; 61(9):1358-64. PubMed ID: 8629297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver transplantation in HBsAg-positive HBV-DNA--negative cirrhotics: immunoprophylaxis and long-term outcome.
    Grazi GL; Mazziotti A; Sama C; Jovine E; Stefanini F; Paladini R; Rossi R; Cavallari A
    Liver Transpl Surg; 1996 Nov; 2(6):418-25. PubMed ID: 9346687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up.
    Mutimer D; Dusheiko G; Barrett C; Grellier L; Ahmed M; Anschuetz G; Burroughs A; Hubscher S; Dhillon AP; Rolles K; Elias E
    Transplantation; 2000 Sep; 70(5):809-15. PubMed ID: 11003363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression.
    Gish RG; Keeffe EB; Lim J; Brooks LJ; Esquivel CO
    J Hepatol; 1995 Mar; 22(3):257-62. PubMed ID: 7608474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha.
    Hopf U; Neuhaus P; Lobeck H; König V; Küther S; Bauditz J; Bechstein WO; Blumhardt G; Steffen R; Neuhaus R
    J Hepatol; 1991 Nov; 13(3):339-46. PubMed ID: 1808226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HBV infection in pediatric liver transplantation.
    Lykavieris P; Fabre M; Yvart J; Alvarez F
    J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):321-7. PubMed ID: 8492264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.
    Bihl F; Russmann S; Gurtner V; Di Giammarino L; Pizzi-Bosman L; Michel M; Cerny A; Hadengue A; Majno P; Giostra E; Castelli D; Mentha G
    BMC Gastroenterol; 2010 Jul; 10():71. PubMed ID: 20598161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation.
    Burbach GJ; Bienzle U; Neuhaus R; Hopf U; Metzger WG; Pratschke J; Neuhaus P
    Transplantation; 1997 Feb; 63(3):478-80. PubMed ID: 9039945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.